IFX-AMFA

N/A

Report date: 2026/04/09 20:00:21

Base Information

Drug NameIFX-AMFA

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Lysosome-Targeting Chimaeras (LYTAC)

Mechanisms of ActionTumor necrosis factor α degraders

TargetsTumor necrosis factor α

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNanoMedSyn

China Registration ClassN/A

Active CompaniesNanoMedSyn

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

ATC CodeN/A